The Operon ElevatePlus phase strengthens your regulatory pathway to ensure your medical device is compliant, approved, and ready for global markets, working across leading regulatory frameworks including Central Drugs Standard Control Organization (CDSCO), Food and Drug Administration (FDA), CE, UKCA, and Saudi Food and Drug Authority (SFDA), aligning strategy, documentation, and execution to meet each market’s requirements. From regulatory planning and technical documentation to audits and approvals, ElevatePlus delivers end-to-end regulatory and compliance support, accelerating approvals, reducing compliance risk, and enabling confident, timely market entry across regions.